TNF and rheumatoid arthritis: In terms of CVD outcomes, a systematic review and meta-analysis of observational cohorts and randomized controlled trials (RCTs) reporting on cardiovascular events in RA patients showed a decrease in CVD risk with the use of anti-TNF therapy [159], but the results of the meta-analysis were not statistically significant.